If approved in RCC, fruquintinib will be available for three indications, including endometrial and colorectal cancer.
Immune Cell Transporters as Mediators of Renal and Vascular Dysfunction and blood pressure Immune cells - including macrophages, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback